In a groundbreaking study recently published in Nature, researchers have uncovered a critical molecular detail that explains how childhood imprinting by influenza H3N2 viruses shapes the antibody response to later H1N1 infections. This discovery hinges on a single amino acid residue—Aspartic acid at position 46 (Asp46)—in the hemagglutinin (HA) stalk region, a target of broadly neutralizing antibodies that cross-react between influenza subtypes. The findings bring new insight into viral immune evasion and have important implications for vaccine design aimed at enhancing broad and durable protection.
Using advanced cryo-electron microscopy (cryo-EM), the research team meticulously resolved atomic structures of two potent broadly neutralizing antibodies isolated from children initially infected with H3N2 strains, complexed with both H3 and H1 hemagglutinin proteins. The overall resolutions of 2.62 to 3.12 Å allowed the authors to visualize the exact antibody binding footprints and subtle conformational differences in the epitopes. Both antibodies targeted the conserved central stalk region of the HA, a domain known for its relatively slow evolution compared to the highly mutable HA head, but they engaged H3 and H1 proteins with distinct angles and interactions, influenced by nearby glycosylation patterns.
Quantitative binding assays confirmed that these antibodies bind with higher affinity to H3 HAs from the imprinting strain than to H1 HAs from subsequent infections, reflecting an “imprinting” or original antigenic sin phenomenon. Structural analyses showed that this difference partly arose from a larger buried surface area and more extensive contacts on the H3 stalk. The epitopes involved key residues on helix A of the HA2 subunit, which govern antibody recognition and neutralizing capacity.
Among critical epitope residues, the study singled out Asp46 in the HA stalk as a pivotal player. Conservation analysis across decades of influenza sequences revealed that while residues Val18 and Leu38 also varied, only Asp46 consistently formed a network of both van der Waals and hydrogen bond interactions with antibody heavy chains. Intriguingly, a substantial fraction of circulating H1N1 and H3N2 strains possess an asparagine residue (Asn) at position 46 instead of Asp, a difference that can profoundly modify electrostatic interactions and binding affinity.
The researchers note that pre-2009 pandemic H1N1 strains typically carry Asn46, correlating with a loss of effective antibody binding, whereas post-2009 and contemporary strains have switched back to Asp46, restoring this critical contact point. Similarly, H3N2 strains have maintained an Asp residue at position 46 since around 2006, likely cementing the formation of robust initial immune memory in children born during this era. This single amino acid substitution thus represents a molecular evolutionary mechanism by which influenza can escape or regain antibody recognition.
To rigorously validate the role of position 46 in antibody binding, the team engineered mutant HA proteins swapping Asp for Asn and vice versa. The results were striking: 87% of the examined broadly neutralizing antibodies showed dramatically increased binding affinity to the H1 strain engineered with the N46D mutation, while 73% exhibited decreased affinity when the H3 strain was mutated to carry D46N. This dependency extended even to inferred germline precursors of these antibodies, suggesting that Asp46 acts as a key determinant for the initial selection and maturation of B cell responses.
Molecular dynamics simulations provided further mechanistic insights into this phenomenon. The interactions of specific antibody residues with Asp46 generated more frequent contacts and greater electrostatic stabilization than with Asn46. The chemical distinction between the side chains—Asp bearing a negatively charged carboxylic acid group and Asn an uncharged amide—creates a subtle yet decisive shift in the electrostatic landscape of the epitope. This altered charge distribution likely facilitates stronger antibody binding, enhancing immune recognition and memory recall.
This molecular finesse highlights the finely balanced evolutionary arms race between influenza viruses and host immunity. Single amino acid changes can substantially influence antigenicity and the success of cross-reactive antibody responses, complicating vaccine-induced protection. Importantly, the study shows how the childhood immune imprint—shaped by exposure to strains with Asp46—limits antibody breadth against earlier strains featuring Asn46, a phenomenon with implications for the timing and composition of influenza vaccines.
Moreover, the authors argue that this detailed understanding of HA stalk interactions could provide new avenues for universal influenza vaccine development. By designing immunogens that stabilize or mimic key residues such as Asp46, it may be possible to direct B cell responses toward epitopes less prone to viral escape, thereby generating broadly protective immunity. These findings underscore the promise and challenges of targeting conserved viral regions, which despite lower variability, can acquire escape mutations with outsized effects.
Overall, these findings chart a new frontier in understanding B cell imprinting, viral evolution, and immune memory dynamics. The study elegantly demonstrates how atomic-level changes drive population-level immune phenomena, providing a rational framework for next-generation influenza vaccine strategies. As influenza viruses continue to evolve rapidly, such mechanistic insights are vital for anticipating viral escape and optimizing immunization approaches for broad and sustained protection.
This work also emphasizes the importance of chronological viral exposure history in shaping lifelong immunity. The presence of Asp46 in imprinting H3N2 viruses creates a molecular “footprint” that steers the specificity and cross-reactivity of memory B cells elicited later in life. In contrast, strains lacking this residue can evade or diminish these imprinted responses, raising key questions about the interplay between viral evolution and host immunity over multiple years and infection cycles.
In sum, the identification of Asp46 as a master key residue governing cross-group HA stalk antibody recognition reshapes our understanding of influenza antigenic variation and immune imprinting. By integrating structural biology, immunology, and evolutionary virology, this research uncovers a crucial molecular determinant of antibody breadth and memory B cell function, with profound implications for combating influenza globally.
Subject of Research:
B cell immune imprinting and molecular determinants of antibody binding specificity in influenza A virus hemagglutinin stalk.
Article Title:
B cell imprinting in children impairs antibodies to the haemagglutinin stalk.
Article References:
Sun, J., Jo, G., Troxell, C.A. et al. B cell imprinting in children impairs antibodies to the haemagglutinin stalk. Nature (2026). https://doi.org/10.1038/s41586-026-10248-6
DOI:
https://doi.org/10.1038/s41586-026-10248-6
Tags: Asp46 amino acid roleatomic resolution antibody mappingbroadly neutralizing influenza antibodieschildhood influenza imprintingcryo-electron microscopy influenza studyglycosylation effects on antibody bindingH3 and H1 hemagglutinin structurehemagglutinin stalk antibodiesinfluenza antibody binding affinityinfluenza H3N2 antibody responseinfluenza viral immune evasionvaccine design for broad protection
